Completed
An Open-Label Extension of a Phase 3 Study of OTX-101 in the Treatment of Keratoconjunctivitis Sicca
NCT02845674
- Conditions
- Conjunctival Diseases, Conjunctivitis, Corneal Diseases, +6 more
- Locations
-
Not specified